On December 26th, Grapevine reported that LIVZON PHARMA (01513.HK) announced a buyback of 0.1453 million shares at a cost of 5.4987 million yuan, with a buyback price per share ranging from 37.72 to 38 yuan.
丽珠医药(01513.HK)12月26日耗资549.87万元回购14.53万股
LIVZON PHARMA (01513.HK) spent 5.4987 million yuan to repurchase 0.1453 million shares on December 26.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.